Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety evaluation of CD3×CD20 bispecific antibodies: a pharmacovigilance study using FDA adverse event reporting system.

BMJ open·2026
Same author

Cyborg-swarm cooperation and game via affective-based brain-machine interface.

National science review·2026
Same author

Advances in oncolytic viruses immunotherapy of hepatocellular carcinoma.

Discover oncology·2026
Same author

Analysis of differential gene expression in potato leaves exposed to low dose ionizing radiation.

Functional & integrative genomics·2026
Same author

Hybrid control scheme of nonlinear model prediction and adaptive terminal sliding mode for underwater vehicles based on threshold switching.

ISA transactions·2026
Same author

Pathogenic Implications of the THY1/NF-κB Feedback Relationship in Osteoarthritis and Its Potential as a Therapeutic Target.

Journal of inflammation research·2026
Same journal

Invaders taking over-Mollusc faunal change in volcanic barrier lakes of the Albertine Rift biodiversity hotspot.

PloS one·2026
Same journal

AI-driven molecular diversification and ligand-based optimization of macitentan derivatives targeting VEGFR1 and endothelin signaling pathways.

PloS one·2026
Same journal

Performance patterns and records in the world aquatics masters championships: Where do the most frequently represented nations among the top-ten masters swimmers come from?

PloS one·2026
Same journal

Modeling diurnal Temperature-Rainfall relationships under multicollinearity using PLS-SEM: A case study of Ghana.

PloS one·2026
Same journal

Organizational culture, social capital, and emergency capacity in primary healthcare institutions: A cross-sectional structural equation modeling study comparing ordinary and older communities.

PloS one·2026
Same journal

Impact of kidney function on the metabolome in the general population.

PloS one·2026
See all related articles

Related Experiment Videos

A data-driven predictive approach for drug delivery using machine learning techniques.

Yuanyuan Li1, Scott C Lenaghan, Mingjun Zhang

  • 1Mechanical, Aerospace and Biomedical Engineering Department, University of Tennessee, Knoxville, Tennessee, United States of America.

Plos One
|March 3, 2012
PubMed
Summary
This summary is machine-generated.

This study introduces a machine learning system to predict drug efficacy and pathogen dynamics, optimizing drug delivery strategies computationally. The approach aids in balancing treatment effectiveness against side effects, offering a scalable solution for drug development.

Related Experiment Videos

Area of Science:

  • Computational biology
  • Pharmacology
  • Infectious diseases

Background:

  • Drug delivery faces a challenge balancing pathogen eradication with patient side effects.
  • Experimental testing of all drug dosing scenarios is often impractical.
  • Computational methods can predict effective drug delivery strategies.

Purpose of the Study:

  • To develop a data-driven, machine learning system for predicting drug dosing effectiveness in silico.
  • To create a scalable, autonomous, and robust framework for analyzing drug-pathogen dynamics.
  • To enable adaptive prediction and optimization of drug treatment strategies.

Main Methods:

  • Developed a data-driven predictive system using machine learning.
  • Incorporated a dynamic model of drug concentration and pathogen population states.
  • Utilized a temporal model to analyze drug-cell interactions adaptively.
  • Validated the system in vitro using Giardia lamblia and metronidazole.

Main Results:

  • The system accurately predicts drug treatment effectiveness and drug-pathogen dynamics.
  • Demonstrated the framework's scalability, autonomy, and robustness.
  • Showcased the ability to adjust model sensitivity and specificity.
  • Successfully validated the proof-of-concept in vitro.

Conclusions:

  • The developed machine learning system offers a powerful computational tool for optimizing drug delivery.
  • This in silico approach can guide the selection of effective dosing strategies, minimizing side effects.
  • The system provides a flexible and adaptive method for predicting treatment outcomes in various applications.